Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Calhoun

Showing results (101-110 of 188) with videos related to

Pageof 19
Sort By:
American Journal of Hypertension|June 1, 2005
Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertensionMari K Nishizaka, Monique Pratt-Ubunama, Mohammad A Zaman, et al.
Hypertension (Dallas, Tex. : 1979)|December 7, 2002
Hyperaldosteronism among black and white subjects with resistant hypertensionDavid A Calhoun, Mari K Nishizaka, Mohammad A Zaman, et al.
American Journal of Hypertension|December 15, 2015
A Message From the New Editorial Team at the American Journal of HypertensionErnesto L Schiffrin, David A Calhoun, John M Flack, et al.
Workplace Health & Safety|July 8, 2014
Characterizing workers participating in a worksite wellness health screening program using blood pressure control, self-monitoring, medication adherence, depression, and exerciseTonya Lynn Breaux-Shropshire, Lauren Whitt, Russell L Griffin, et al.
Journal of the American Society of Hypertension : JASH|October 26, 2011
Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patientsMaria Czarina Acelajado, Roberto Pisoni, Tanja Dudenbostel, et al.
Circulation|June 3, 2004
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronismMari K Nishizaka, M Amin Zaman, Sharon A Green, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 14, 2008
Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trialWilliam B White, David A Calhoun, Rita Samuel, et al.
American Journal of Hypertension|January 15, 2011
Moderate waist circumference and hypertension prevalence: the REGARDS StudyDeborah A Levine, David A Calhoun, Ronald J Prineas, et al.
Hypertension (Dallas, Tex. : 1979)|December 7, 2020
Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone SecretionMohammed Siddiqui, Eric K Judd, Bin Zhang, et al.
Current Medical Research and Opinion|July 3, 2008
Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertensionDavid A Calhoun, Robert D Glazer, Frank S Pettyjohn, et al.
Pageof 19

Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
American Journal of Hypertension|June 1, 2005
Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertensionMari K Nishizaka, Monique Pratt-Ubunama, Mohammad A Zaman, et al.
Hypertension (Dallas, Tex. : 1979)|December 7, 2002
Hyperaldosteronism among black and white subjects with resistant hypertensionDavid A Calhoun, Mari K Nishizaka, Mohammad A Zaman, et al.
American Journal of Hypertension|December 15, 2015
A Message From the New Editorial Team at the American Journal of HypertensionErnesto L Schiffrin, David A Calhoun, John M Flack, et al.
Workplace Health & Safety|July 8, 2014
Characterizing workers participating in a worksite wellness health screening program using blood pressure control, self-monitoring, medication adherence, depression, and exerciseTonya Lynn Breaux-Shropshire, Lauren Whitt, Russell L Griffin, et al.
Journal of the American Society of Hypertension : JASH|October 26, 2011
Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patientsMaria Czarina Acelajado, Roberto Pisoni, Tanja Dudenbostel, et al.
Circulation|June 3, 2004
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronismMari K Nishizaka, M Amin Zaman, Sharon A Green, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 14, 2008
Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trialWilliam B White, David A Calhoun, Rita Samuel, et al.
American Journal of Hypertension|January 15, 2011
Moderate waist circumference and hypertension prevalence: the REGARDS StudyDeborah A Levine, David A Calhoun, Ronald J Prineas, et al.
Hypertension (Dallas, Tex. : 1979)|December 7, 2020
Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone SecretionMohammed Siddiqui, Eric K Judd, Bin Zhang, et al.
Current Medical Research and Opinion|July 3, 2008
Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertensionDavid A Calhoun, Robert D Glazer, Frank S Pettyjohn, et al.
Pageof 19